about
CureVac NV is a biopharmaceutical company headquartered in Germany that is developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA) that has the potential to improve the lives of people. CureVac had a collaboratio...
Read More
5.39
0.04
(0.75%)
372.8K
XNAS Volume
XNAS 30 Sep, 2025 5:30 PM (EDT)
Not Eligible
Affordable Valuation
Technically Moderately Bullish
CureVac NV Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..